1. Home
  2. RELI vs QNRX Comparison

RELI vs QNRX Comparison

Compare RELI & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELI
  • QNRX
  • Stock Information
  • Founded
  • RELI 2013
  • QNRX 2018
  • Country
  • RELI United States
  • QNRX United States
  • Employees
  • RELI N/A
  • QNRX N/A
  • Industry
  • RELI Specialty Insurers
  • QNRX Medical/Dental Instruments
  • Sector
  • RELI Finance
  • QNRX Health Care
  • Exchange
  • RELI Nasdaq
  • QNRX Nasdaq
  • Market Cap
  • RELI 3.0M
  • QNRX 3.3M
  • IPO Year
  • RELI N/A
  • QNRX N/A
  • Fundamental
  • Price
  • RELI $1.22
  • QNRX $7.70
  • Analyst Decision
  • RELI
  • QNRX
  • Analyst Count
  • RELI 0
  • QNRX 0
  • Target Price
  • RELI N/A
  • QNRX N/A
  • AVG Volume (30 Days)
  • RELI 54.9K
  • QNRX 528.4K
  • Earning Date
  • RELI 05-14-2025
  • QNRX 05-13-2025
  • Dividend Yield
  • RELI N/A
  • QNRX N/A
  • EPS Growth
  • RELI N/A
  • QNRX N/A
  • EPS
  • RELI N/A
  • QNRX N/A
  • Revenue
  • RELI $14,208,143.00
  • QNRX N/A
  • Revenue This Year
  • RELI N/A
  • QNRX N/A
  • Revenue Next Year
  • RELI N/A
  • QNRX N/A
  • P/E Ratio
  • RELI N/A
  • QNRX N/A
  • Revenue Growth
  • RELI 2.40
  • QNRX N/A
  • 52 Week Low
  • RELI $0.97
  • QNRX $5.01
  • 52 Week High
  • RELI $18.53
  • QNRX $54.95
  • Technical
  • Relative Strength Index (RSI)
  • RELI 55.58
  • QNRX 58.05
  • Support Level
  • RELI $1.01
  • QNRX $6.21
  • Resistance Level
  • RELI $1.33
  • QNRX $9.63
  • Average True Range (ATR)
  • RELI 0.09
  • QNRX 0.80
  • MACD
  • RELI 0.02
  • QNRX 0.29
  • Stochastic Oscillator
  • RELI 65.63
  • QNRX 46.83

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: